62 related articles for article (PubMed ID: 12871893)
1. Discontinuation of hormone therapy and bone mineral density: does physical activity modify that relationship?
Sheedy AN; Wactawski-Wende J; Hovey KM; LaMonte MJ
Menopause; 2023 Dec; 30(12):1199-1205. PubMed ID: 38019034
[TBL] [Abstract][Full Text] [Related]
2. Association between Bone Quality and Physical Activity in Community-Dwelling Older Adults.
Akai K; Nagai K; Tsuji S; Hirose K; Maruyama D; Matsuzawa R; Tamaki K; Kusunoki H; Wada Y; Shinmura K
Geriatrics (Basel); 2024 May; 9(3):. PubMed ID: 38804319
[TBL] [Abstract][Full Text] [Related]
3. Postmenopausal Osteoporosis: Menopause Hormone Therapy and Selective Estrogen Receptor Modulators.
Rani J; Swati S; Meeta M; Singh SH; Tanvir T; Madan A
Indian J Orthop; 2023 Dec; 57(Suppl 1):105-114. PubMed ID: 38107817
[TBL] [Abstract][Full Text] [Related]
4. Abnormal Trabecular Bone Score, Lower Bone Mineral Density and Lean Mass in Young Women With Premature Ovarian Insufficiency Are Prevented by Oestrogen Replacement.
Samad N; Nguyen HH; Hashimura H; Pasco J; Kotowicz M; Strauss BJ; Ebeling PR; Milat F; Vincent AJ
Front Endocrinol (Lausanne); 2022; 13():860853. PubMed ID: 35663323
[TBL] [Abstract][Full Text] [Related]
5. Risk of osteoporosis and fracture after hysterectomies without oophorectomies: a systematic review and pooled analysis.
Xu W; Wu W; Yang S; Chen T; Teng X; Gao D; Zhao S
Osteoporos Int; 2022 Aug; 33(8):1677-1686. PubMed ID: 35348837
[TBL] [Abstract][Full Text] [Related]
6. Effect of Tibolone on Bone Mineral Density in Postmenopausal Women: Systematic Review and Meta-Analysis.
Castrejón-Delgado L; Castelán-Martínez OD; Clark P; Garduño-Espinosa J; Mendoza-Núñez VM; Sánchez-Rodríguez MA
Biology (Basel); 2021 Mar; 10(3):. PubMed ID: 33802101
[TBL] [Abstract][Full Text] [Related]
7. Effect of anthocyanin-rich bilberry extract on bone metabolism in ovariectomized rats.
Shimizu S; Matsushita H; Morii Y; Ohyama Y; Morita N; Tachibana R; Watanabe K; Wakatsuki A
Biomed Rep; 2018 Feb; 8(2):198-204. PubMed ID: 29435281
[TBL] [Abstract][Full Text] [Related]
8. Long-term supplementation with young coconut juice does not prevent bone loss but rather alleviates body weight gain in ovariectomized rats.
Matsushita H; Minami A; Kanazawa H; Suzuki T; Subhadhirasakul S; Watanabe K; Wakatsuki A
Biomed Rep; 2017 May; 6(5):585-591. PubMed ID: 28529739
[TBL] [Abstract][Full Text] [Related]
9. Emerging potential of parenteral estrogen as androgen deprivation therapy for prostate cancer.
Ali Shah SI
South Asian J Cancer; 2015; 4(2):95-7. PubMed ID: 25992351
[TBL] [Abstract][Full Text] [Related]
10. The FRAX ® as a predictor of mortality in Japanese incident hemodialysis patients: an observational, follow-up study.
Hayashi T; Joki N; Tanaka Y; Iwasaki M; Kubo S; Asakawa T; Matsukane A; Takahashi Y; Imamura Y; Hirahata K; Hase H
J Bone Miner Metab; 2015 Nov; 33(6):674-83. PubMed ID: 25691284
[TBL] [Abstract][Full Text] [Related]
11. Postmenopausal hormone therapy: risks and benefits.
Rozenberg S; Vandromme J; Antoine C
Nat Rev Endocrinol; 2013 Apr; 9(4):216-27. PubMed ID: 23419265
[TBL] [Abstract][Full Text] [Related]
12. Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects.
Stanczyk FZ; Hapgood JP; Winer S; Mishell DR
Endocr Rev; 2013 Apr; 34(2):171-208. PubMed ID: 23238854
[TBL] [Abstract][Full Text] [Related]
13. Systematic review of methods used in meta-analyses where a primary outcome is an adverse or unintended event.
Warren FC; Abrams KR; Golder S; Sutton AJ
BMC Med Res Methodol; 2012 May; 12():64. PubMed ID: 22553987
[TBL] [Abstract][Full Text] [Related]
14. Update on hormonal contraception and bone density.
Isley MM; Kaunitz AM
Rev Endocr Metab Disord; 2011 Jun; 12(2):93-106. PubMed ID: 21559817
[TBL] [Abstract][Full Text] [Related]
15. Lean body mass, not estrogen or progesterone, predicts peak bone mineral density in premenopausal women.
Lu LJ; Nayeem F; Anderson KE; Grady JJ; Nagamani M
J Nutr; 2009 Feb; 139(2):250-6. PubMed ID: 19106315
[TBL] [Abstract][Full Text] [Related]
16. Effects of tibolone and raloxifene on bone mineral density in osteopenic postmenopausal women.
Delmas PD; Davis SR; Hensen J; Adami S; van Os S; Nijland EA
Osteoporos Int; 2008 Aug; 19(8):1153-60. PubMed ID: 18256777
[TBL] [Abstract][Full Text] [Related]
17. Effects of specific post-menopausal hormone therapies on bone mineral density in post-menopausal women: a meta-analysis.
Dören M; Nilsson JA; Johnell O
Hum Reprod; 2003 Aug; 18(8):1737-46. PubMed ID: 12871893
[TBL] [Abstract][Full Text] [Related]
18. [Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone].
Reginster JY
J Gynecol Obstet Biol Reprod (Paris); 2002 Oct; 31(6):541-9. PubMed ID: 12407324
[TBL] [Abstract][Full Text] [Related]
19. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.
Cauley JA; Robbins J; Chen Z; Cummings SR; Jackson RD; LaCroix AZ; LeBoff M; Lewis CE; McGowan J; Neuner J; Pettinger M; Stefanick ML; Wactawski-Wende J; Watts NB;
JAMA; 2003 Oct; 290(13):1729-38. PubMed ID: 14519707
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
